RxDoctor Payments Data

Alvin Yan

Physician Assistant · Newport Beach, CANPI 1245859560

Payments from drug & device makers

$11,880in general payments, 2019–2025

Across 606 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Amgen$2K
  • Novartis$1K
  • UCB, Inc.$1K
  • Johnson & Johnson$993
  • GSK$991
  • plus $3K from 21 others

What the payments were for

  • Travel & lodging$20%
  • Food & beverage$11,857100%
  • Education$210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,880 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab42$303,687
Cosentyx Unoready PenSecukinumab11$170,454
Enbrel SureclickEtanercept12$116,193
Actemra ActpenTocilizumab23$94,205
EnbrelEtanercept12$85,450
ProliaDenosumab36$58,522
Teriparatide15$36,864
RasuvoMethotrexate/Pf27$15,714
Hydroxychloroquine Sulfate318$7,042
Mycophenolate Mofetil43$4,536
MethotrexateMethotrexate Sodium328$4,273
Zoledronic AcidZoledronic Acid/Mannitol-Water23$3,122
Colchicine70$2,069
Leflunomide29$1,812
Gabapentin141$1,600

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEnbrel, Prolia$1,662$143,97248 claims
Alvogen IncTeriparatide$20$36,86415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Newport Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →